Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
SGMOQ
$0.16
+4.63%
SGMOQ
· Sangamo Therapeutics, Inc
$0.16
+0.01 (+4.63%)
At close · Aug 28
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about our ability to continue to operate as a going concern. We will need substantial additional funding in the very near term to execute our operating plan and to continue to operate as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$66.29M
Shares
414.29M
All earnings calls
Earnings call · FY2021 Q2
Sangamo Therapeutics, Inc (SGMOQ) Q2 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$27.87M
+29.3% YoY
Diluted EPS
-$0.33
Net income
-$47.17M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2021 · complete as-filed document